At the time of this articles publication, weve completed typing over 100,000 households to identify current users, lapsed users, and non-users of GLP-1 medications, with additional views into use case and time on the drug
in 2021, a larger amount of semaglutide, rebranded as Wegovy, was FDA-approved for people with obesity or who are overweight and have health problems related to that excess weight
This guide offers practical tips on latch, milk supply, common challenges, and more to help you navigate breastfeeding with confidence
Many people prescribed GLP-1s for weight loss report GI side effects and a drastically reduced appetite, which can make it incredibly difficult to eat enough to meet basic needs let alone thrive
Increased levels of physical activity (PA) are linked to improved condition-specific health outcomes in individuals with type 1 diabetes (T1D) (31)